These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2014582)

  • 21. Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma.
    Rozhansky F; Chen MH; Cox MC; Dahut W; Figg WD; D'Amico AV
    Cancer; 2006 Jan; 106(1):63-7. PubMed ID: 16333854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy: is it effective in treatment of prostatic cancer?
    Murphy GP
    Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Satraplatin in the treatment of hormone-refractory prostate cancer.
    Sternberg CN
    BJU Int; 2005 Nov; 96(7):990-4. PubMed ID: 16225514
    [No Abstract]   [Full Text] [Related]  

  • 24. A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma.
    Eisenberger MA; Bezerdjian L; Kalash S
    Urol Clin North Am; 1987 Nov; 14(4):695-706. PubMed ID: 3314063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.
    Eisenberger MA; Simon R; O'Dwyer PJ; Wittes RE; Friedman MA
    J Clin Oncol; 1985 Jun; 3(6):827-41. PubMed ID: 2409240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Docetaxel--standard therapy further optimized].
    Krankenpfl J; 2005; 43(4-6):141. PubMed ID: 16171083
    [No Abstract]   [Full Text] [Related]  

  • 27. [New treatment approach to hormone-refractory prostate carcinoma].
    Rexer H
    Urologe A; 2007 Jul; 46(7):786-8. PubMed ID: 17598082
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemo-hormonal therapy for prostate cancer].
    Igawa T
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():539-43. PubMed ID: 22208040
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate cancer. Chemotherapy.
    Gibbons RP
    Cancer; 1987 Aug; 60(3 Suppl):586-8. PubMed ID: 3297287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antineoplastic chemotherapies (including hormone therapy). Classification and mechanism of action].
    Clavel M
    Rev Prat; 1991 Dec; 41(26):2759-65. PubMed ID: 1808694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Specific immunotherapy in metastasizing breast cancer combined with chemotherapy. A prospective randomized study].
    Graninger W; Bettelheim P; Jakesz R; Rainer H; Moser K; Mörz R; Miksche M
    Acta Med Austriaca Suppl; 1979; 6():322-4. PubMed ID: 299220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update in cancer chemotherapy: genitourinary tract cancer, Part 3: Cancer of the prostate.
    Wright JC
    J Natl Med Assoc; 1988 Mar; 80(3):305-14. PubMed ID: 3280813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrasentan prolongs time to progression in prostate cancer patients.
    Oncology (Williston Park); 2001 Jul; 15(7):833, 917. PubMed ID: 11499685
    [No Abstract]   [Full Text] [Related]  

  • 34. Stanford experience with chemotherapy for metastatic prostate cancer.
    Torti FM; Reese J; Freiha F
    Prog Clin Biol Res; 1990; 350():171-85. PubMed ID: 1696740
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of carcinoma of the prostate. Comparison between single and multiple drug therapy.
    King KM; Hofstetter AM
    Pa Med; 1975 Mar; 78(3):61-2. PubMed ID: 1168889
    [No Abstract]   [Full Text] [Related]  

  • 36. [The contribution of hormone therapy (single or combined) to the prognosis of solid tumors].
    Longueville J
    Rev Med Liege; 1984 Feb; 39(3):108-10. PubMed ID: 6718862
    [No Abstract]   [Full Text] [Related]  

  • 37. Is "off-protocol" chemotherapy for androgen-independent carcinoma of prostate warranted?
    Mani S; Vogelzang NJ
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):749-68. PubMed ID: 8773509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone.
    Murphy GP; Beckley S; Brady MF; Chu TM; deKernion JB; Dhabuwala C; Gaeta JF; Gibbons RP; Loening SA; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Soloway MS
    Cancer; 1983 Apr; 51(7):1264-72. PubMed ID: 6337697
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
    Tannock IF
    J Clin Oncol; 1985 Jul; 3(7):1013-21. PubMed ID: 3894584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research in drug development for advanced prostate cancer.
    Eisenberger M
    Clin Adv Hematol Oncol; 2018 Jan; 16(1):42-44. PubMed ID: 29741504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.